Yves Pommier
18Patents
4h-index
52Co-inventors
63Inventor score
Filing activity: Oct 23, 1992 → Jan 11, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6291676A | Water-soluble derivatives of camptothecin/homocamptothecin | Chemistry; Metallurgy | 30 | Expired |
| US5622960A | Topoisomerase II inhibitors and therapeutic uses therefor | Chemistry; Metallurgy | 9 | Expired |
| US6355785B1 | Guanosine-rich oligonucleotide integrase inhibitors | Electricity | 4 | Expired |
| US5747520A | Topoisomerase II inhibitors and therapeutic uses therefor | Chemistry; Metallurgy | 4 | Expired |
| US5606060A | Topoisomerase II inhibitors and therapeutic uses therefor | Chemistry; Metallurgy | 3 | Expired |
| US6825206B1 | Camptothecin compounds with a thioether group | Human Necessities | 2 | Expired |
| US10906914B2 | Furoquinolinediones as inhibitors of TDP2 | Chemistry; Metallurgy | 1 | Active |
| US11999747B2 | Furoquinolinediones as inhibitors of TDP2 | Chemistry; Metallurgy | 0 | Active |
| US8865686B2 | Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7015212B1 | Thiazepine inhibitors of HIV-1 integrase | Human Necessities | 0 | Expired |
| US7776883B2 | Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and AIDS related complex (ARC) | Physics | 0 | Active |
| US8765802B2 | Kinase inhibitors, compositions thereof, and methods of use therewith | Chemistry; Metallurgy | 0 | Active |
| US8716295B2 | Fluoroquinolone derivatives or sulfonamide moiety-containing compounds as inhibitors of tyrosyl-dnaphosphodiesterase (TDP1) | Chemistry; Metallurgy | 0 | Active |
| US8912214B2 | Use of Chk2 kinase inhibitors for cancer treatment | Chemistry; Metallurgy | 0 | Active |
| US9278089B2 | Method of treating HCV infection with a small molecule CHK2 inhibitor | Chemistry; Metallurgy | 0 | Active |
| US8278100B2 | Lasonolide compounds as reagents for inducing premature chromosome condensation and methods for treating disorders | Human Necessities | 0 | Active |
| US10208035B2 | Compounds for inhibiting drug-resistant strains of HIV-1 integrase | Chemistry; Metallurgy | 0 | Active |
| US9676771B2 | Compounds for inhibiting drug-resistant strains of HIV-1 integrase | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.